软组织肿瘤分级与分期简介ppt课件.pptx

上传人:飞****2 文档编号:70260490 上传时间:2023-01-18 格式:PPTX 页数:49 大小:3.17MB
返回 下载 相关 举报
软组织肿瘤分级与分期简介ppt课件.pptx_第1页
第1页 / 共49页
软组织肿瘤分级与分期简介ppt课件.pptx_第2页
第2页 / 共49页
点击查看更多>>
资源描述

《软组织肿瘤分级与分期简介ppt课件.pptx》由会员分享,可在线阅读,更多相关《软组织肿瘤分级与分期简介ppt课件.pptx(49页珍藏版)》请在taowenge.com淘文阁网|工程机械CAD图纸|机械工程制图|CAD装配图下载|SolidWorks_CaTia_CAD_UG_PROE_设计图分享下载上搜索。

1、认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目软组织肿瘤的分级与分期简介吴焕文认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目prognosisPrognosisofSTSisdominatedbylocalrecurrenceanddistantmetastasis.Overallsurvivalmainlydependsonmetastasis,butinsomelocalizations,suchasretroperitonealareas,ove

2、rallsurvivaldependsalsoonlocalrecurrence.Inmostreportedstudies,qualityofsurgicalmarginsisthemostimportantfactorforpredictinglocalrecurrence,whereasmetastasisandoverallsurvivalarerelatedmainlytohistologicgrade.Histopathologicalgradingfavourableprognosisorpoorprognosis;overallsurvival;appropriatetreat

3、mentregimenselection(Surgical,chemotherapeutic,andradiationtreatments)soft-tissuesarcomasprognosticfactors认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目Gradingofsofttissuesarcomaswasfirstproposedin1939byBroders,whousedacombinationofmitoticactivity,tumorgiantcells,andfibrousstromainassig

4、ningagradetofibrosarcomas.Brodersalsoacknowledgedtheimportanceofcellulardifferentiationingrading.ThefirstcoherentandeffectiveprognosticclassificationofSTSwasproposedbyRusselletal.in1977.ThissystemintroducedahistologicgradingapplicabletoalladultSTSs,whichwasthemostimportantfactor.Somehistologicaltype

5、ofTumorsaredefinitionallyhighgradeorlowgrade.Anumberofdifferentgradingsystemshavebeenproposedovertheyearsforsofttissuesarcomas,utilizing2tiered,3tiered,and4tieredstratificationschemes.lFrenchFederationofCancerCenters(FNCLCC)system(37.3%)lNationalCancerInstitute(NCI)(24%),lBroderscriteria(12%)lMarkhe

6、desystem(1.3%)lother(15.3%)认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目PARAMETERSUSEDINGRADING:lHistologicaltypelNecrosislMitoticactivitylTumourdifferentiationlCellularitylNuclearpleomorphismlVascularinvasion认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目Themostwidelyuseda

7、ndclinicallyvalidatedgradingsystemsare:NationalCancerInstitute(NCI)systemFrenchFederationofCancerCenters(FNCLCC)systemBothofwhichare3tieredsystems(Grade1,Grade2,Grade3).Atthepresenttime,theFNCLCCgradingsystemeaseofuseinterobserveragreementpredictivepower认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,

8、已经展开了“精准扶贫”项目NationalCancerInstitute(NCI)gradingsystemCriteriaforgradinghistologicdiagnosiscellularitycellularpleomorphismmitoticratenecrosis:necrosisemergedasamajordiscriminatingvariable.grade2and3tumorsexhibitingmoderateormarkednecrosis(15%)hadasignificantlypoorerprognosis.Three-gradesystemTheresp

9、ective5-yearsurvivalratesl100%(GradeI)l73%(GradeII)l46%(GradeIII)认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目NATIONALCANCERINSTITUTEGRADINGSYSTEM(NCI分级系统)分级系统)Gradinginthissystemisbasedonhistologicaltypeoftumourandtumournecrosiswherehistologicaltypedoesnotdefinegrade.HISTOLOGICALPARAM

10、ETERGRADEHISTOLOGICALTYPE/SUBTYPE1-Epithelioidhaemangioendothelioma-Welldifferentiatedliposarcoma-Myxoidliposarcoma-InfantilefibrosarcomaHISTOLOGICALTYPE,MITOSIS,DIFFERENTIATION1-Well-differentiatedleiomyosarcoma(6mitosis/10HPF)-Well-differentiatedfibrosarcoma(6mitosis/10HPF)-Malignantperipheralnerv

11、esheathtumour(5cminmaximumdiameter.N0Noclinicalregionallymphnodeinvolvement.N1Clinicalregionallymphnodeinvolvement.NXRegionallymphnodesnotexamined;noinformation.M0Nometastaticdisease.M1Metastaticdisease.认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目StageSitesofPrimaryTumorTStageTumorSiz

12、eRegionalLymphNodesDistantMetastasisIFavorablesites T1orT2AnysizeN0orN1orNX M0IIUnfavorablesitesT1orT2a,5cmN0orNXM0IIIUnfavorablesitesT1orT2a,5cmN1M0b,5cmN0orN1orNXIVAnysiteT1orT2AnysizeN0orN1orNX M1M0=absenceofmetastaticspread;M1=presenceofmetastaticspreadbeyondtheprimarysite;N0=absenceofnodalsprea

13、d;N1=presenceofnodalspreadbeyondtheprimarysite;X=unknownNstatus.Soft Tissue Sarcoma Committee of the Childrens Oncology Group Pretreatment Staging System 认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目GroupDefinitionI(Approximately13%ofallpatientsareinthisgroup.)Alocalizedtumorthatiscomp

14、letelyremovedwithpathologicallyclearmarginsandnoregionallymphnodeinvolvement.II(Approximately20%ofallpatientsareinthisgroup.)Alocalizedtumorthatisgrosslyremovedwith(a)microscopicdiseaseatthemargin,(b)involved,grosslyremovedregionallymphnodes,or(c)both(a)and(b).III(Approximately48%ofallpatientsareint

15、hisgroup.)Alocalizedtumorwithgrossresidualdiseaseafterincompleteremovalorbiopsyonly.IV(Approximately18%ofallpatientsareinthisgroup.)Distantmetastasesarepresentatdiagnosis.RiskGroupHistologyStageGroupLowriskEmbryonal1I,II,IIIEmbryonal2,3I,IIIntermediateriskEmbryonal2,3IIIAlveolar1,2,3I,II,IIIHighrisk

16、EmbryonalorAlveolar4IVSoft Tissue Sarcoma Committee of the Childrens Oncology Group Surgico-pathologic Group System SoftTissueSarcomaCommitteeoftheChildrensOncologyGroupRhabdomyosarcomaRiskGroupClassification认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目Prognosticparametersnotcurrentlyi

17、ncludedinthepresentAJCCSTSstagingsystemlAgeAgewasthemostconsistentadverseindependentprognosticfactorforsurvival.lNeurovascularandboneinvasionindependentpredictors:malignantfibroushistiocytomas;leiomyosarcomas;synovialsarcoma;认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目lHistologicsubty

18、pechildrenandadolescentsnon-rhabdomyosarcomasofttissuesarcoma(NRSTS):lessresponsivetoradiotherapyrhabdomyosarcoma:radiotherapycanbeusedinsteadofsurgeryembryonalsubtypesalveolarsubtypesretroperitonealsarcomas(RPSs)atypicallipomatoustumors(ALTs),non-ALTliposarcomas(LPSs)other认识到了贫困户贫困的根本原因,才能开始对症下药,然后

19、药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目lSiteofprimarydisease:认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目lSpecificmolecularprognosticmarkersllocalrecurrenceMostanalysesident

20、ifypreviouslocalrecurrenceasamajor(ifnotthemajor)riskfactorforsubsequentlocalrecurrence.认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目lMarginstatusPositivesurgicalmarginsarethemainpredictorsforlocalrelapse.Grade,size,andTNMstage(UICC/AJCC)havestrongerprognosticsignificanceforoverallsurv

21、ivalanddistantrecurrencethanforlocalrelapse.Itisbelievedgenerallythatsurgicalmarginsoflessthan1.5-2cminsofttissuesarcomapredisposetoanincreasedriskoflocalrecurrenceunlessfurthersurgeryorirradiationisundertaken.Howeverifasurgicalmarginisboundedbyanunbreachedlayeroffasciaorperiosteumthisriskprobablydo

22、esnotapply,butsuchmarginsshouldstillbemeasuredifclose.认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目EndpointAdversePrognosticFactorRelativeRiskLocalrecurrenceFibrosarcoma2.5Localrecurrenceatpresentation2.0Microscopicallypositivemargin1.8Malignantperipheralnervesheathtumor1.8Age50years1.

23、6DistantrecurrenceHighgrade4.3Deeplocation2.5Size5.09.9cm1.9Leiomyosarcoma1.7Nonliposarcomahistology1.6Localrecurrenceatpresentation1.5Size10.0cm1.5Disease-specificHighGrade4.0survivalDeeplocation2.8Size10.0cm2.1Malignantperipheralnervesheathtumor1.9Leiomyosarcoma1.9Microscopicallypositivemargin1.7L

24、owerextremitysite1.6Localrecurrenceatpresentation1.5MultivariateAnalysisofPrognosticFactorsinPatientswithExtremitySoft-TissueSarcoma认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目RECOMMENDATIONSFORTHEREPORTINGOFSOFTTISSUESARCOMAD

25、iagnosticInformation1.Siteanddepthoftumor(e.g.dermal,subcutaneous,fascial,subfascial,intramuscular,visceralormorethanoneofthese).2.Histologicaltype(useWHOsystemwhenpossible);iftumortypeisunknownthenthetermunclassifiedsarcomawithaqualifiersuchaspleomorphic,spindlecell,myxoidorroundcellisuseful.3.Maxi

26、maldimensionoftumor(incm);4.Histologicgrade;5.Minimumdistance(s)toresectionmargins-anymarginlessthan2cmfromthetumorshouldbespecifiedintermsoflocationanddistance;认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目6.Histologicevidenceofapre-existingbenignlesion(onlyapplicabletonervesheathneopl

27、asms);7.Lymphnodestatus(ifpresent);8.Resultsofanyspecialinvestigations(e.g.specialstains,immunohistochemistry,electronmicroscopy,DNAflowcytometry,karyotype).认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重视,已经展开了“精准扶贫”项目1.Mitoticrate,expressedasnumberofmitosesper10highpowerfields;2.Extentofnecrosis,asco

28、nfirmedhistologically;3.Presenceorabsenceofvascularinvasion,irrespectiveofvesseltype;4.Characteroflesionalmargin-e.g.circumscribed,focallyinfiltrative,diffuselyinfiltrative;5.Presence,extentandtypeofinflammatoryinfiltrate.OptionalFeaturesinDiagnosticReport认识到了贫困户贫困的根本原因,才能开始对症下药,然后药到病除。近年来国家对扶贫工作高度重

29、视,已经展开了“精准扶贫”项目参考文献1.TrojaniM,ContessoG,CoindreJM,RouesseJ,BuiNB,deMascarelA,GoussotJF,DavidM,BonichonF,LagardeC(1984).Soft-tissuesarcomasofadults;studyofpathologicalprognosticvariablesanddefinitionofahistopathologicalgradingsystem.IntJCancer33:37-42.2.HasegawaT.HistologicalgradingandMIB-1labelingin

30、dexofsoft-tissuesarcomas.PatholInt.2007Mar;57(3):121-5.3.CostaJ(1990).Thegradingandstagingofsofttissuesarcomas.In:PathobiologyofSoftTissueTumors,FletcherCD,McKeePH,eds.ChurchillLivingstone:Edinburgh,pp.221-238.4.CostaJ,WesleyRA,GlatsteinE,RosenbergSA(1984).Thegradingofsofttissuesarcomas.Resultsofacl

31、inicohistopathologiccorrelationinaseriesof163cases.Cancer53:530-541.5.RiadS,GriffinAM,LibermanB,etal.Lymphnodemetastasisinsofttissuesarcomainanextremity.ClinOrthopRelatRes2004;426:129346.HasegawaT,YokoyamaR,LeeYH,ShimodaT,BeppuY,HirohashiS.PrognosticrelevanceofahistologicalgradingsystemusingMIB-1for

32、adultsoft-tissuesarcoma.Oncology2000;58:6674.7.HasegawaT,YamamotoS,YokoyamaR,UmedaT,MatsunoY,HirohashiS.PrognosticsignificanceofgradingandstagingsystemsusingMIB-1scoreinadultpatientswithsofttissuesarcomaoftheextremitiesandtrunk.Cancer2002;95:8438.FletcherCD,BermanJJ,CorlessC,etal.Diagnosisofgastrointestinalstromaltumors:aconsensusapproach.Hum Pathol2002;33:45965.

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 教育专区 > 教案示例

本站为文档C TO C交易模式,本站只提供存储空间、用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。本站仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知淘文阁网,我们立即给予删除!客服QQ:136780468 微信:18945177775 电话:18904686070

工信部备案号:黑ICP备15003705号© 2020-2023 www.taowenge.com 淘文阁